IMC Chicago LLC Takes $1.08 Million Position in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)

IMC Chicago LLC purchased a new stake in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 22,406 shares of the exchange traded fund's stock, valued at approximately $1,080,000. IMC Chicago LLC owned 2.02% of ProShares Ultra Nasdaq Biotechnology as of its most recent SEC filing.

Separately, Tower Research Capital LLC TRC lifted its stake in shares of ProShares Ultra Nasdaq Biotechnology by 31.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 5,326 shares of the exchange traded fund's stock valued at $270,000 after purchasing an additional 1,266 shares during the period.

ProShares Ultra Nasdaq Biotechnology Stock Down 1.7%

Shares of ProShares Ultra Nasdaq Biotechnology stock traded down $0.82 during trading on Friday, reaching $47.17. 2,149 shares of the company were exchanged, compared to its average volume of 11,811. The business has a 50-day moving average price of $43.34 and a 200-day moving average price of $50.01. The firm has a market capitalization of $51.89 million, a price-to-earnings ratio of 20.68 and a beta of 1.63. ProShares Ultra Nasdaq Biotechnology has a twelve month low of $33.78 and a twelve month high of $69.56.

ProShares Ultra Nasdaq Biotechnology Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, April 1st. Stockholders of record on Wednesday, March 26th were given a dividend of $0.1309 per share. The ex-dividend date was Wednesday, March 26th. This represents a $0.52 annualized dividend and a dividend yield of 1.11%.

ProShares Ultra Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.